[india-drug] E-drug: WHO/EDM Technical Briefing Seminar No 6

["Dr. Hogerzeil" <hogerzeilh@who.int>]

WHO/EDM Technical Briefing E-drug:  Seminar No 6 
Geneva, 29 September - 3 October 2003
 
----------------------------------------------------------

Dear all,

Please find below the first formal announcement of a one-week 
Technical Briefing Seminar which the WHO Department of Essential Drugs
and Medicines Policy will organize in Geneva in September/October 2003.
 Similar briefing seminars have been held annually since 1998. This
year's programme includes updates on the Global Fund, the UN 
pre-qualification project, the procedures for updating and
disseminating the WHO Model List of Essential Medicines, the web-based
Essential Medicines Library, Rational Use of Medicines, and the
implications of international trade agreements. 

Already, 35 people have expressed interest in attending while our 
Capacity is limited. This means that regrettably a number of potential 
Participants may be disappointed.

As in previous years, participation at the seminar is free of charge 
But participants will have to arrange for their own travel, board and 
lodging.

Requests for application forms can be sent to Mrs A. Wilberforce,
WHO/EDM/PAR, 1211 Geneva, fax 41-22-7914167, or e-mail
wilberforcea@who.int. The WHO Department of Essential Drugs and 
Medicines Policy will not be able to sponsor any participants.

Dr Hans V. Hogerzeil  MD, PhD, FRCP (Edin)
Coordinator for Policy, Access and Rational Use
Department of Essential Drugs and Medicines Policy
World Health Organization, 1211 Geneva 27
Tel: 41.22.791.3528, Fax: 41.22.791.4167




WHO Technical Briefing Seminar for international and national staff 
Active in pharmaceutical support programmes.

Organized by:  WHO Department of Essential Drugs and Medicines
Policy (WHO/EDM), in collaboration with UNICEF Supply Division, 
Copenhagen
Venue:	WHO Headquarters, Geneva, Salle G (8th floor)
Dates: 29 September - 3 October 2003

Target audience:
Technical advisers and field staff of WHO, UNICEF, other UN and 
Bilateral agencies, governmental  and non-governmental organizations
active in pharmaceutical and health sector reform programmes in
developing countries.

Meeting objectives:
By the end of the programme, participants will: 
1. have a general understanding of the most common problems in the
pharmaceutical sector in developing countries; 
2.  have a general understanding of how WHO and the UNICEF Supply
Division support developing countries in strengthening the 
Pharmaceutical sector;
3.  appreciate the importance of national drug policies as the best
approach to make essential drugs of good quality available to all who 
need them, and ensure the rational use of drugs;
4.  be aware of ways to strengthen collaboration with WHO and other
organizations supporting the pharmaceutical sector in developing
countries.

Structure of sessions:
1.  Presentation (20-30 minutes) of main problems at country level, 
key approaches/ strategies, practical aspects of assistance to Member 
States, and key documents
2.  30 minutes of small group discussion on the basis of 3-4 
discussion points
3.  Presentations by group - discussion

Resource persons:
Most presentations and discussions will be lead by senior staff 
members of the WHO Department of Essential Drugs and Medicines Policy
and one session by staff of UNICEF. Time has been reserved for an
optional session and for individual appointments with WHO staff .

Applications:
Participation at the Technical Briefing Seminar is free of charge; 
But participants will have to arrange for their own travel, board and
lodging*.  WHO/EDM is not in a position to financially support 
applicants.

Requests for application forms can be sent to Mrs A. Wilberforce,
WHO/EDM/PAR, 1211 Geneva, Fax:  41.22.791.4167, or e-mail
wilberforcea@who.int <mailto:wilberforcea@who.int>.  Applicants will 
be requested to fill in an application form giving contact details and 
an explanation as to why they consider themselves a good candidate for
selection.  Those applicants who are not able to attend the full four 
and a half days are strongly discouraged from applying.

Admission to the seminar will be confirmed by mid August at the 
latest.



Provisional Outline of programme
(Resource persons and exact time-table subject to confirmation)

Monday 29 September 2003
Registration  
Introduction  			Welcome
Introductory presentation 
Introduction of participants:
Gallery of experts
25 Years of Essential Drugs-Impact & Challenges

Selection of Essential Medicines WHO Model List of Essential
Medicines: Update 2003
Evidence-based approach
Essential Medicines Library web-based demonstration 
National Medicines Policies-Indicators

Evening	          	               Reception 

Tuesday 30 September
What is access? 			
Access to essential medicines
Access to HIV/AIDS medicines 
Access to antimalarial medicines

Procurement and supply	
Drug procurement, supply and distribution, (UNICEF) 

Evening    				
Joint dinner in the old town of Geneva

Wednesday 1 October
What is quality? 			
Drug regulation and quality assurance
WHO normative functions in the field of pharmaceuticals
Pre-qualification of antiretroviral, antimalarial
and antituberculosis drugs
Assessment of regulatory capacity at country level

Drug Prices and Financing		
Differential Pricing 
WHO/NGO Price Survey Methodology
Generic Policies

Thursday 2 October
What is rational drug use?	
Promoting rational drug use

Country programmes					
Optional extra session, as decided by the participants

Friday 3 October 
     Global issues	
Impact of globalisation,
international trade agreements
Global medicines funds 
International coordination 
12.30   Closure






________________________________________________________________________
Missed your favourite TV serial last night? Try the new, Yahoo! TV.
       visit http://in.tv.yahoo.com
The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@healthnet.org